{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:21:42Z","timestamp":1791397302495,"version":"4.3.3"},"reference-count":182,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS 043205"],"award-info":[{"award-number":["NS 043205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS41930"],"award-info":[{"award-number":["NS41930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS44310"],"award-info":[{"award-number":["NS44310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011103","name":"European Union 6th Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union 7th Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","award":["666918"],"award-info":[{"award-number":["666918"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sparks Foundation"},{"DOI":"10.13039\/100005468","name":"BDSRA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010446","name":"BDFA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011516","name":"Beyond Batten Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011516","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NCL Stiftung"},{"name":"The Saoirse Foundation"},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Natalie Fund"},{"name":"The Bletsoe Family"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbadis.2019.165570","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T12:41:13Z","timestamp":1572698473000},"page":"165570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Pathomechanisms in the neuronal ceroid lipofuscinoses"],"prefix":"10.1016","volume":"1866","author":[{"given":"Hemanth R.","family":"Nelvagal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta A.","family":"Tarczyluk-Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.165570_bb0005","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbadis.2012.08.012","article-title":"The neuronal ceroid-lipofuscinoses: a historical introduction","volume":"1832","author":"Haltia","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0015","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases - clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165570_bb0020","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165570_bb0025","first-page":"1","article-title":"Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses","volume":"16","author":"Mukherjee","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2019.165570_bb0030","first-page":"873","article-title":"Pathogenesis of neuronal ceroid lipofuscinosis","volume":"762","author":"Cooper","year":"2012","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0035","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bbadis.2012.11.014","article-title":"Human pathology in NCL","volume":"1832","author":"Anderson","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165570_bb0040","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0045","doi-asserted-by":"crossref","unstructured":"A. Kohlschutter, A. Schulz, Towards understanding the neuronal ceroid lipofuscinoses, Brain Dev. 31 (2009) 499\u2013502. doi:S0387-7604(08)00293-3 [pii]https:\/\/doi.org\/10.1016\/j.braindev.2008.12.008.","DOI":"10.1016\/j.braindev.2008.12.008"},{"key":"10.1016\/j.bbadis.2019.165570_bb0050","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","article-title":"NCL disease mechanisms","volume":"1832","author":"Palmer","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165570_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0167-4943(02)00011-0","article-title":"The origin of fluorescence in the neuronal ceroid lipofuscinoses (Batten disease) and neuron cultures from affected sheep for studies of neurodegeneration","volume":"34","author":"Palmer","year":"2002","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.bbadis.2019.165570_bb0060","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2005.12.006","article-title":"You say lipofuscin, we say ceroid: defining autofluorescent storage material","volume":"27","author":"Seehafer","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165570_bb0065","first-page":"1","article-title":"Lysosomal storage diseases","volume":"25","author":"Ferreira","year":"2017","journal-title":"Metab. Dis. Found. Clin. Manag. Genet. Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbadis.2019.165570_bb0075","doi-asserted-by":"crossref","unstructured":"A. Sun, Lysosomal storage disease overview, Ann. Transl. Med. 6 (2018) 476. doi:10.21037\/atm.2018.11.39.","DOI":"10.21037\/atm.2018.11.39"},{"key":"10.1016\/j.bbadis.2019.165570_bb0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","article-title":"Neurodegenerative lysosomal disorders: a continuum from development to late age","volume":"4","author":"Nixon","year":"2008","journal-title":"Autophagy."},{"key":"10.1016\/j.bbadis.2019.165570_bb0085","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41593-018-0221-2","article-title":"Selective vulnerability in neurodegenerative diseases","volume":"21","author":"Fu","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for batten disease. The batten mouse model consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/13868","article-title":"The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8","volume":"23","author":"Ranta","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0100","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1523\/JNEUROSCI.20-18-06898.2000","article-title":"Deficiency induces lysosomal storage with Ceroid Lipofuscin in mouse CNS neurons","volume":"20","author":"Koike","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0105","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","article-title":"Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165570_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338190","article-title":"Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse","volume":"70","author":"Gao","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0115","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/hmg\/ddh312","article-title":"A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging","volume":"13","author":"Kopra","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0120","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2004.08.013","article-title":"Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons","volume":"18","author":"Jalanko","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0130","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/MCB.26.6.2309-2316.2006","article-title":"Murine Cathepsin F deficiency causes neuronal Lipofuscinosis and late-onset neurological disease","volume":"26","author":"Tang","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2353\/ajpath.2010.090915","article-title":"Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging","volume":"177","author":"Ahmed","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0140","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited \u03b1-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2012.03.003","article-title":"Mouse models of neuronal ceroid lipofuscinoses: useful pre-clinical tools to delineate disease pathophysiology and validate therapeutics","volume":"88","author":"Shacka","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbadis.2019.165570_bb0150","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/acn3.144","article-title":"Mice homozygous for c.451C>T mutation in Cln1 gene recapitulate INCL phenotype","volume":"1","author":"Bouchelion","year":"2014","journal-title":"Ann Clin Transl Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/hmg\/ddu428","article-title":"The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy","volume":"24","author":"Miller","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/ddv615","article-title":"Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7","volume":"25","author":"Brandenstein","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176526","article-title":"A tailored mouse model of CLN2 disease: a nonsense mutant for testing personalized therapies","volume":"12","author":"Geraets","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165570_bb0175","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbrc.2004.12.038","article-title":"A mutation in the CLN8 gene in English setter dogs with neuronal ceroid-lipofuscinosis","volume":"327","author":"Katz","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2005.11.005","article-title":"A mutation in the cathepsin D gene (CTSD) in American bulldogs with neuronal ceroid lipofuscinosis","volume":"87","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2010.04.009","article-title":"A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund","volume":"100","author":"Sanders","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0190","first-page":"198042","article-title":"A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis","volume":"2011","author":"Katz","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2016.12.007","article-title":"Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenl\u00e4ndische Dachsbracke dog","volume":"120","author":"Hirz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nbd.2017.08.017","article-title":"Canine neuronal ceroid lipofuscinoses: promising models for preclinical testing of therapeutic interventions","volume":"108","author":"Katz","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0205","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bbadis.2015.06.013","article-title":"Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the batten animal research network","volume":"1852","author":"Palmer","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.165570_bb0210","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1038\/s41598-019-45859-9","article-title":"CRISPR\/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)","volume":"9","author":"Eaton","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0215","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2018.12.198","article-title":"Characterization of a novel porcine model of CLN3-batten disease","volume":"126","author":"Johnson","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s002340050427","article-title":"MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type","volume":"39","author":"Autti","year":"1997","journal-title":"Neuroradiology."},{"key":"10.1016\/j.bbadis.2019.165570_bb0225","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3174\/ajnr.A4816","article-title":"Volumetric description of brain atrophy in neuronal ceroid lipofuscinosis 2: Supratentorial gray matter shows uniform disease progression","volume":"37","author":"L\u00f6bel","year":"2016","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0230","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3174\/ajnr.A4978","article-title":"MRI brain volume measurements in infantile neuronal ceroid lipofuscinosis","volume":"38","author":"Baker","year":"2017","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0235","doi-asserted-by":"crossref","unstructured":"C.C. Pontikis, S.L. Cotman, M.E. MacDonald, J.D. Cooper, Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7\/8 knock-in mouse model of Batten disease, Neurobiol Dis. 20 (2005) 823\u2013836. doi:S0969-9961(05)00153-1 [pii]https:\/\/doi.org\/10.1016\/j.nbd.2005.05.018.","DOI":"10.1016\/j.nbd.2005.05.018"},{"key":"10.1016\/j.bbadis.2019.165570_bb0240","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0245","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nbd.2009.02.001","article-title":"Progressive thalamocortical neuron loss in Cln5 deficient mice: distinct effects in Finnish variant late infantile NCL","volume":"34","author":"von Schantz","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0250","doi-asserted-by":"crossref","unstructured":"M. Kuronen, A.E. Lehesjoki, A. Jalanko, J.D. Cooper, O. Kopra, Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice, Neurobiol Dis. 47 (2012) 444\u2013457. doi:S0969-9961(12)00164-7 [pii]https:\/\/doi.org\/10.1016\/j.nbd.2012.04.018.","DOI":"10.1016\/j.nbd.2012.04.018"},{"key":"10.1016\/j.bbadis.2019.165570_bb0255","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1523\/JNEUROSCI.4295-15.2016","article-title":"An EEG investigation of sleep homeostasis in healthy and CLN5 batten disease affected sheep","volume":"36","author":"Perentos","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0260","doi-asserted-by":"crossref","unstructured":"M.J. Oswald, D.N. Palmer, G.W. Kay, S.J. Shemilt, P. Rezaie, J.D. Cooper, Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6), Neurobiol Dis. 20 (2005) 49\u201363. doi:S0969-9961(05)00044-6 [pii]https:\/\/doi.org\/10.1016\/j.nbd.2005.01.025.","DOI":"10.1016\/j.nbd.2005.01.025"},{"key":"10.1016\/j.bbadis.2019.165570_bb0265","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nbd.2008.06.004","article-title":"Location and connectivity determine GABAergic interneuron survival in the brains of South Hampshire sheep with CLN6 neuronal ceroid lipofuscinosis","volume":"32","author":"Oswald","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.401","article-title":"Molecular neuropathology of the synapse in sheep with CLN5 Batten disease","volume":"5","author":"Amorim","year":"2015","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbadis.2019.165570_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1096","article-title":"Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses","volume":"8","author":"Russell","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbadis.2019.165570_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038310","article-title":"Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system","volume":"7","author":"Staropoli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165570_bb0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2350\/07-03-0242.1","article-title":"A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera","volume":"11","author":"Galvin","year":"2008","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0290","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.yexmp.2014.10.003","article-title":"Neuronal ceroid lipofuscinosis genes, CLN2, CLN3 and CLN5 are spatially and temporally co-expressed in a developing mouse brain","volume":"97","author":"Fabritius","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0295","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","article-title":"Cell biology of the NCL proteins: what they do and don\u2019t do","volume":"1852","author":"C\u00e1rcel-Trullols","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0300","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.dib.2016.06.027","article-title":"Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin","volume":"8","author":"Minye","year":"2016","journal-title":"Data Br."},{"key":"10.1016\/j.bbadis.2019.165570_bb0305","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/AJP.0000000000000192","article-title":"A case-controlled investigation of pain experience and sensory function in neuronal ceroid lipofuscinosis","volume":"31","author":"Barney","year":"2015","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.bbadis.2019.165570_bb0310","first-page":"E5920","article-title":"Synergistic effects of treating the spinal cord and brain in CLN1 disease","volume":"144","author":"Shyng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.165570_bb0315","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0320","doi-asserted-by":"crossref","unstructured":"M.L. Katz, L. Tecedor, Y. Chen, B.G. Williamson, E. Lysenko, F.A. Wininger, W.M. Young, G.C. Johnson, R.E. Whiting, J.R. Coates, B.L. Davidson, AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease, Sci Transl Med. 7 (2015) 313ra180. doi:https:\/\/doi.org\/10.1126\/scitranslmed.aac6191.","DOI":"10.1126\/scitranslmed.aac6191"},{"key":"10.1016\/j.bbadis.2019.165570_bb0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2016.12.007","article-title":"Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenlandische Dachsbracke dog","volume":"120","author":"Hirz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0330","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ddrr.1118","article-title":"The neuronal ceroid-lipofuscinoses","volume":"17","author":"Bennett","year":"2013","journal-title":"Dev Disabil Res Rev."},{"key":"10.1016\/j.bbadis.2019.165570_bb0335","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/bjophthalmol-2015-307320","article-title":"Novel morphological macular findings in juvenile CLN3 disease","volume":"100","author":"Dulz","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0340","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/mcne.2001.1099","article-title":"Retinal pathology and function in a Cln3 knockout mouse model of juvenile neuronal Ceroid Lipofuscinosis (batten disease)","volume":"19","author":"Seigel","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0345","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41598-017-01716-1","article-title":"Retinal degeneration in a mouse model of CLN5 disease is associated with compromised autophagy","volume":"7","author":"Leinonen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0350","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13816810.2016.1210651","article-title":"Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life","volume":"38","author":"Preising","year":"2017","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0355","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-319-75402-4_50","article-title":"Further characterization of the predominant inner retinal degeneration of aging Cln3 \u0394ex7\/8 knock-in mice","volume":"1074","author":"Volz","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0360","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/2051-5960-2-54","article-title":"Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography","volume":"2","author":"Groh","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0365","doi-asserted-by":"crossref","unstructured":"J.M. Weimer, A.W. Custer, J.W. Benedict, N.A. Alexander, E. Kingsley, H.J. Federoff, J.D. Cooper, D.A. Pearce, Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons, Neurobiol Dis. 22 (2006) 284\u2013293. doi:S0969-9961(05)00311-6 [pii]https:\/\/doi.org\/10.1016\/j.nbd.2005.11.008.","DOI":"10.1016\/j.nbd.2005.11.008"},{"key":"10.1016\/j.bbadis.2019.165570_bb0370","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.eye.6701770","article-title":"Progression of early postnatal retinal pathology in a mouse model of neuronal ceroid lipofuscinosis","volume":"19","author":"Seigel","year":"2005","journal-title":"Eye."},{"key":"10.1016\/j.bbadis.2019.165570_bb0375","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1044-7431(03)00035-6","article-title":"Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice","volume":"22","author":"Koike","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0380","doi-asserted-by":"crossref","unstructured":"M.L. Katz, G.S. Johnson, G.E. Tullis, B. Lei, Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis, Neurobiol Dis. 29 (2008) 242\u2013253. doi:S0969-9961(07)00202-1 [pii]https:\/\/doi.org\/10.1016\/j.nbd.2007.08.017.","DOI":"10.1016\/j.nbd.2007.08.017"},{"key":"10.1016\/j.bbadis.2019.165570_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021908","article-title":"Knock-down of cathepsin D affects the retinal pigment epithelium, impairs swim-bladder ontogenesis and causes premature death in zebrafish","volume":"6","author":"Follo","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbadis.2019.165570_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ae907882-62e0-4803-8c00-35b30a649fe9","article-title":"Progressive retinal degeneration and glial activation in the CLN6nclf mouse model of neuronal Ceroid Lipofuscinosis: a beneficial effect of DHA and Curcumin supplementation","volume":"8","author":"Mirza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165570_bb0395","doi-asserted-by":"crossref","unstructured":"J. Guo, G.S. Johnson, H.A. Brown, M.L. Provencher, R.C. da Costa, T. Mhlanga-Mutangadura, J.F. Taylor, R.D. Schnabel, D.P. O'Brien, M.L. Katz, A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian shepherd ancestry, Mol. Genet. Metab. 112 (2014) 302\u20139. doi:https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.014.","DOI":"10.1016\/j.ymgme.2014.05.014"},{"key":"10.1016\/j.bbadis.2019.165570_bb0400","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.16-20158","article-title":"Retinal degeneration in mice deficient in the lysosomal membrane protein CLN7","volume":"57","author":"Jankowiak","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/nyas.12990","article-title":"Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)","volume":"1371","author":"Ouseph","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0410","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","article-title":"Cln3(Deltaex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth","volume":"11","author":"Cotman","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0415","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1101\/lm.034355.114","article-title":"Higher brain functions served by the lowly rodent primary visual cortex","volume":"15","author":"Gavornik","year":"2014","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0420","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","article-title":"Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Bible","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0425","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1093\/hmg\/ddp355","article-title":"Molecular correlates of axonal and synaptic pathology in mouse models of batten disease","volume":"18","author":"Kielar","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078694","article-title":"A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165570_bb0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/nen.0b013e31815f3899","article-title":"Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis","volume":"67","author":"Partanen","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a4b06d46-8eb9-4d15-a15a-41bf4b5ccb8b","article-title":"Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis","volume":"7","author":"Thelen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.165570_bb0445","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2169\/internalmedicine.34.1158","article-title":"A family with adult type Ceroid Lipofuscinosis (Kufs\u2019 disease) and heart muscle disease: report of two autopsy cases","volume":"34","author":"Sakajiri","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbadis.2019.165570_bb0450","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1212\/WNL.0b013e31821435bd","article-title":"Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"76","author":"Ostergaard","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.bbadis.2019.165570_bb0455","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1469-8749.2011.04170.x","article-title":"Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis","volume":"54","author":"Fukumura","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0460","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymgme.2016.05.008","article-title":"Neuronal ceroid lipofuscinosis associated with an MFSD8 mutation in Chihuahuas","volume":"118","author":"Ashwini","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2019.165570_bb0465","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gt.2017.4","article-title":"Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression","volume":"24","author":"Katz","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbadis.2019.165570_bb0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2018.07.003","article-title":"Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (batten disease)","volume":"214","author":"Ostergaard","year":"2018","journal-title":"Auton. Neurosci. Basic Clin."},{"key":"10.1016\/j.bbadis.2019.165570_bb0475","first-page":"73","article-title":"Juvenile neuronal ceroid lipofuscinosis (batten disease): current insights","volume":"6","author":"Ostergaard","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0480","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/mds.25669","article-title":"Neurophysiology of gait: from the spinal cord to the frontal lobe","volume":"28","author":"Takakusaki","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2019.165570_bb0485","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.bbadis.2015.04.022","article-title":"The neuronal ceroid lipofuscinoses: opportunities from model systems","volume":"1852","author":"Faller","year":"2015","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0490","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/cns.12330","article-title":"Degeneration and regeneration of GABAergic interneurons in the dentate Gyrus of adult mice in experimental models of epilepsy","volume":"21","author":"Wei","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbadis.2019.165570_bb0495","first-page":"205","article-title":"Inhibitory interneurons in Alzheimer\u2019s disease","volume":"119","author":"Vargova","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"key":"10.1016\/j.bbadis.2019.165570_bb0500","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1038\/s41598-017-14966-w","article-title":"TDP-43 accelerates age-dependent degeneration of interneurons","volume":"7","author":"Tsuiji","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0505","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neubiorev.2018.05.021","article-title":"A new outlook on cholinergic interneurons in Parkinson\u2019s disease and L-DOPA-induced dyskinesia","volume":"92","author":"Conti","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2019.165570_bb0510","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2015.08.005","article-title":"The interneuron energy hypothesis: implications for brain disease","volume":"90","author":"Kann","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0515","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.expneurol.2009.01.022","article-title":"Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse","volume":"217","author":"Macauley","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0520","doi-asserted-by":"crossref","unstructured":"J.M. Weimer, J.W. Benedict, A.L. Getty, C.C. Pontikis, M.J. Lim, J.D. Cooper, D.A. Pearce, Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis, Brain Res. 1266 (2009) 93\u2013107. doi:S0006-8993(09)00291-1 [pii]https:\/\/doi.org\/10.1016\/j.brainres.2009.02.009.","DOI":"10.1016\/j.brainres.2009.02.009"},{"key":"10.1016\/j.bbadis.2019.165570_bb0525","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1042\/BST0381436","article-title":"Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy","volume":"38","author":"Walkley","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2019.165570_bb0530","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neurobiolaging.2008.06.011","article-title":"Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP\/PS1KI mouse model of Alzheimer\u2019s disease","volume":"31","author":"Wirths","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2019.165570_bb0535","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnins.2015.00417","article-title":"Neuroinflammatory paradigms in lysosomal storage diseases","volume":"9","author":"Bosch","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0540","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/nan.12338","article-title":"Review: astrocytes in Alzheimer\u2019s disease and other age-associated dementias: a supporting player with a central role","volume":"43","author":"Garwood","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0545","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbadis.2019.165570_bb0550","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in physiology and disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0555","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-017-0476-y","article-title":"Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons","volume":"5","author":"Parviainen","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0560","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-018-0575-4","article-title":"Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis","volume":"6","author":"Lange","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0565","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/brain\/awt020","article-title":"Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"136","author":"Groh","year":"2013","journal-title":"Brain."},{"key":"10.1016\/j.bbadis.2019.165570_bb0570","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/glia.22962","article-title":"Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease","volume":"64","author":"Groh","year":"2016","journal-title":"Glia."},{"key":"10.1016\/j.bbadis.2019.165570_bb0575","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/hmg\/11.12.1421","article-title":"An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder batten disease","volume":"11","author":"Chattopadhyay","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0580","doi-asserted-by":"crossref","unstructured":"S.S. Seehafer, D. Ramirez-Montealegre, A.M. Wong, C.H. Chan, J. Castaneda, M. Horak, S.M. Ahmadi, M.J. Lim, J.D. Cooper, D.A. Pearce, Immunosuppression alters disease severity in juvenile Batten disease mice, J Neuroimmunol. 230 (2011) 169\u2013172. doi:S0165-5728(10)00405-4 [pii]https:\/\/doi.org\/10.1016\/j.jneuroim.2010.08.024.","DOI":"10.1016\/j.jneuroim.2010.08.024"},{"key":"10.1016\/j.bbadis.2019.165570_bb0585","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","article-title":"An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis","volume":"34","author":"Macauley","year":"2014","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2019.165570_bb0590","first-page":"655","article-title":"(CLN3 disease): emerging disease-modifying therapeutic strategies","volume":"13","author":"Augustine","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bbadis.2019.165570_bb0595","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and Teriflunomide attenuate Neurodegeneration in mouse models of neuronal Ceroid Lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2019.165570_bb0600","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.ph.28.030166.002251","article-title":"Functions of lysosomes","volume":"28","author":"De Duve","year":"1966","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0605","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2004.05293.x","article-title":"Lysosomal storage disorders","volume":"128","author":"Vellodi","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0610","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.nbd.2018.05.015","article-title":"Lysosome trafficking and signaling in health and neurodegenerative diseases","volume":"122","author":"Lie","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0615","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.201607005","article-title":"The lysosome as a command-and-control center for cellular metabolism","volume":"214","author":"Lim","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15252\/emmm.201505966","article-title":"The awesome lysosome","volume":"8","author":"Ballabio","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2019.165570_bb0625","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control Centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat Rev Mol Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0630","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4161\/auto.19469","article-title":"Autophagy in lysosomal storage disorders","volume":"8","author":"Lieberman","year":"2012","journal-title":"Autophagy."},{"key":"10.1016\/j.bbadis.2019.165570_bb0635","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0640","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/ars.2011.4405","article-title":"Lysosomal function and dysfunction: mechanism and disease","volume":"17","author":"Boya","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2019.165570_bb0645","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41598-018-36379-z","article-title":"Autophagy\u2013lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease","volume":"9","author":"Adams","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0650","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0002-9440(10)61253-9","article-title":"Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (batten disease)","volume":"167","author":"Koike","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0655","doi-asserted-by":"crossref","first-page":"20483","DOI":"10.1074\/jbc.M602180200","article-title":"Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"281","author":"Cao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0660","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2017.01.001","article-title":"Characterisation of early changes in ovine CLN5 and CLN6 batten disease neural cultures for the rapid screening of therapeutics","volume":"100","author":"Best","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0665","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbalip.2016.01.006","article-title":"Autophagy, lipophagy and lysosomal lipid storage disorders","volume":"1861","author":"Ward","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.bbadis.2019.165570_bb0670","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/10.1.69","article-title":"Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)","volume":"10","author":"Lehtovirta","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0675","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.nbd.2005.03.012","article-title":"Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice","volume":"20","author":"Virmani","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0680","doi-asserted-by":"crossref","unstructured":"B. Gr\u00fcnewald, M.D. Lange, C. Werner, A. O'Leary, A. Weishaupt, S. Popp, D.A. Pearce, H. Wiendl, A. Reif, H.C. Pape, K. V. Toyka, C. Sommer, C. Geis, 2017. Defective synaptic transmission causes disease signs in a mouse model of juvenile neuronal ceroid lipofuscinosis, Elife, 6. pii: e28685. doi:https:\/\/doi.org\/10.7554\/eLife.28685.","DOI":"10.7554\/eLife.28685"},{"key":"10.1016\/j.bbadis.2019.165570_bb0685","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1038\/s41598-017-12603-0","article-title":"Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo","volume":"7","author":"Llavero Hurtado","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0690","doi-asserted-by":"crossref","unstructured":"K.P. Koster, W. Francesconi, F. Berton, S. Alahmadi, R. Srinivas, A. Yoshii, 2019. Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model, Elife, 8. pii: e40316. doi:https:\/\/doi.org\/10.7554\/eLife.40316.","DOI":"10.7554\/eLife.40316"},{"key":"10.1016\/j.bbadis.2019.165570_bb0695","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.15252\/embj.201591125","article-title":"Regulation of synaptic activity by snapin-mediated endolysosomal transport and sorting","volume":"34","author":"Di Giovanni","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2019.165570_bb0700","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1083\/jcb.201704068","article-title":"Activity-dependent trafficking of lysosomes in dendrites and dendritic spines","volume":"216","author":"Goo","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0705","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2017.01.026","article-title":"Bassoon controls presynaptic autophagy through Atg5","volume":"93","author":"Okerlund","year":"2017","journal-title":"Neuron."},{"key":"10.1016\/j.bbadis.2019.165570_bb0710","doi-asserted-by":"crossref","unstructured":"I. Sambri, R. D'Alessio, Y. Ezhova, T. Giuliano, N.C. Sorrentino, V. Cacace, M. De Risi, M. Cataldi, L. Annunziato, E. De Leonibus, A. Fraldi, Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases, EMBO Mol. Med. 9 (2017) 112\u2013132. doi:10.15252\/emmm.201606965.","DOI":"10.15252\/emmm.201606965"},{"key":"10.1016\/j.bbadis.2019.165570_bb0715","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jnc.13713","article-title":"Synaptopathies: synaptic dysfunction in neurological disorders \u2013 a review from students to students","volume":"138","author":"Lepeta","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0720","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/pr.116.013342","article-title":"Synaptic vesicle-recycling machinery components as potential therapeutic targets","volume":"69","author":"Li","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2019.165570_bb0725","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1042\/BST20140188","article-title":"Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?","volume":"42","author":"Shyng","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2019.165570_bb0730","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1113\/JP270988","article-title":"Role of astrocyte\u2013synapse interactions in CNS disorders","volume":"595","author":"Blanco-Su\u00e1rez","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0735","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0740","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00221-017-4928-1","article-title":"Astrocytes and synaptic plasticity in health and disease","volume":"235","author":"Singh","year":"2017","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.bbadis.2019.165570_bb0745","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1074\/jbc.M114.621706","article-title":"Unbiased cell-based screening in a neuronal cell model of batten disease highlights an interaction between Ca2+ homeostasis, autophagy, and CLN3 protein function","volume":"290","author":"Chandrachud","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0750","doi-asserted-by":"crossref","unstructured":"E. Lloyd-Evans, Acidic Ca2+ stores in neurodegeneration., Messenger (Los Angeles, Calif. Print). 5 (2016) 37\u201355. doi:10.1166\/msr.2016.1054.","DOI":"10.1166\/msr.2016.1054"},{"key":"10.1016\/j.bbadis.2019.165570_bb0755","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1039\/C4MT00032C","article-title":"Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses?","volume":"6","author":"Grubman","year":"2014","journal-title":"Metallomics."},{"key":"10.1016\/j.bbadis.2019.165570_bb0760","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1750-3639.2003.tb00486.x","article-title":"Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency","volume":"13","author":"Nijssen","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0765","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jnr.20549","article-title":"Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2","volume":"81","author":"Goswami","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2019.165570_bb0770","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2121-8-22","article-title":"Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1)--distinct characteristics in neurons","volume":"8","author":"Lyly","year":"2007","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0775","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.tcb.2014.06.006","article-title":"Lysosome: regulator of lipid degradation pathways","volume":"24","author":"Settembre","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0780","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4161\/auto.5227","article-title":"Lysosomal storage diseases as disorders of autophagy","volume":"4","author":"Settembre","year":"2008","journal-title":"Autophagy."},{"key":"10.1016\/j.bbadis.2019.165570_bb0785","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-neuro-070815-014031","article-title":"Brain disorders due to Lysosomal dysfunction","volume":"39","author":"Fraldi","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0790","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-neuro-080317-061804","article-title":"Lysosomes and brain health","volume":"41","author":"Sharma","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0795","doi-asserted-by":"crossref","first-page":"14612","DOI":"10.1038\/ncomms14612","article-title":"Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model","volume":"8","author":"Bagh","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0800","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/hmg\/ddy076","article-title":"Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation","volume":"27","author":"Danyukova","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.165570_bb0805","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-18-0706","article-title":"PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer","volume":"9","author":"Rebecca","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2019.165570_bb0810","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/2159-8290.CD-17-0741","article-title":"A unified approach to targeting the lysosome\u2019s degradative and growth signaling roles","volume":"7","author":"Rebecca","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2019.165570_bb0815","doi-asserted-by":"crossref","unstructured":"C.J. Holler, G. Taylor, Z.T. McEachin, Q. Deng, W.J. Watkins, K. Hudson, C.A. Easley, W.T. Hu, C.M. Hales, W. Rossoll, G.J. Bassell, T. Kukar, Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia, Mol. Neurodegener. 11 (2016) 46. doi:https:\/\/doi.org\/10.1186\/s13024-016-0114-3.","DOI":"10.1186\/s13024-016-0114-3"},{"key":"10.1016\/j.bbadis.2019.165570_bb0820","doi-asserted-by":"crossref","unstructured":"M. Palmieri, R. Pal, H.R. Nelvagal, P. Lotfi, G.R. Stinnett, M.L. Seymour, A. Chaudhury, L. Bajaj, V. V Bondar, L. Bremner, U. Saleem, D.Y. Tse, D. Sanagasetti, S.M. Wu, J.R. Neilson, F.A. Pereira, R.G. Pautler, G.G. Rodney, J.D. Cooper, M. Sardiello, mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases, Nat Commun. 8 (2017) 14338. doi:https:\/\/doi.org\/10.1038\/ncomms14338.","DOI":"10.1038\/ncomms14338"},{"key":"10.1016\/j.bbadis.2019.165570_bb0825","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fneur.2019.00963","article-title":"Combined anti-inflammatory and Neuroprotective treatments have the potential to impact disease phenotypes in Cln3\u2212\/\u2212 mice","volume":"10","author":"Tarczyluk-Wells","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0830","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13023-017-0663-8","article-title":"Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders","volume":"12","author":"Kim","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0835","doi-asserted-by":"crossref","first-page":"38922","DOI":"10.1074\/jbc.M112.365148","article-title":"Gemfibrozil and fenofibrate, food and drug administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor \u03b1: implications for late infantile batten disease therapy","volume":"287","author":"Ghosh","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0840","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1074\/jbc.M114.610659","article-title":"Activation of peroxisome proliferator-activated receptor \u03b1 induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders","volume":"290","author":"Ghosh","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.165570_bb0845","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11626-015-9979-7","article-title":"Fibrates inhibit the apoptosis of batten disease lymphoblast cells via autophagy recovery and regulation of mitochondrial membrane potential","volume":"52","author":"Hong","year":"2016","journal-title":"Vitr. Cell. Dev. Biol. - Anim."},{"key":"10.1016\/j.bbadis.2019.165570_bb0850","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/86554","article-title":"Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood","volume":"7","author":"Zhang","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2019.165570_bb0855","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0860","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/nn.3526","article-title":"Neuroprotection and lifespan extension in Ppt1(\u2212\/\u2212) mice by NtBuHA: therapeutic implications for INCL","volume":"16","author":"Sarkar","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2019.165570_bb0865","doi-asserted-by":"crossref","unstructured":"A.D. Kovacs, A. Saje, A. Wong, S. Ramji, J.D. Cooper, D.A. Pearce, Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease, Neuropharmacology. 63 (2012) 769\u201375. doi:S0028\u20133908(12)00248\u20131 [pii]https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.040.","DOI":"10.1016\/j.neuropharm.2012.05.040"},{"key":"10.1016\/j.bbadis.2019.165570_bb0870","doi-asserted-by":"crossref","unstructured":"A.D. Kovacs, A. Saje, A. Wong, G. Szenasi, P. Kiricsi, E. Szabo, J.D. Cooper, D.A. Pearce, Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease, Neuropharmacology. 60 (2011) 405\u2013409. doi:S0028\u20133908(10)00280\u20137 [pii]https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.010.","DOI":"10.1016\/j.neuropharm.2010.10.010"},{"key":"10.1016\/j.bbadis.2019.165570_bb0875","first-page":"117","article-title":"Short-term administration of mycophenolate is well-tolerated in CLN3 disease (Juvenile neuronal ceroid lipofuscinosis)","volume":"43","author":"Augustine","year":"2019","journal-title":"JIMD Rep."},{"key":"10.1016\/j.bbadis.2019.165570_bb0880","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(14)70142-5","article-title":"Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study","volume":"13","author":"Levin","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0885","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13023-016-0414-2","article-title":"Moving towards effective therapeutic strategies for neuronal Ceroid Lipofuscinosis","volume":"11","author":"Geraets","year":"2016","journal-title":"Orphanet J Rare Dis."},{"key":"10.1016\/j.bbadis.2019.165570_bb0890","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41556-018-0228-7","article-title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis","volume":"20","author":"di Ronza","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0895","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbrc.2017.05.002","article-title":"Identification of CLN6 as a molecular entity of endoplasmic reticulum-driven anti-aggregate activity","volume":"487","author":"Yamashita","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.165570_bb0900","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2121-10-83","article-title":"Novel interactions of CLN5 support molecular networking between neuronal Ceroid Lipofuscinosis proteins","volume":"10","author":"Lyly","year":"2009","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.bbadis.2019.165570_bb0905","doi-asserted-by":"crossref","unstructured":"M. McLaren, S. Mathavarajah, R. Huber, 2019. Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum, Cells. 8(2) pii: E115. doi:https:\/\/doi.org\/10.3390\/cells8020115.","DOI":"10.3390\/cells8020115"},{"key":"10.1016\/j.bbadis.2019.165570_bb0910","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jmcb\/mjt022","article-title":"The lysosome: from waste bag to potential therapeutic target","volume":"5","author":"Appelqvist","year":"2013","journal-title":"J. Mol. Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:55:46Z","timestamp":1760417746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919302935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0925443919302935"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165570","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathomechanisms in the neuronal ceroid lipofuscinoses","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.165570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165570"}}